MIBio 2019 Programme

08:00 Registration opens 

09:00 Opening remarks

09:15 IgG Interactions – from biophysics to biology
Tom Laue – Professor of Biochemistry, University of New Hampshire, USA 

09:45 Size matters: role of aggregates in protein immunogenicity
Wim Jiskoot – Professor of Drug Delivery, Biologics Formulation Group, University of Leiden, The Netherlands

10:15 Speed Networking

11:15 Comparative evaluation of chelating agents to prevent polysorbates and API degradation in biologic formulations
Riccardo Torosantucci – Section Head, Formulation & Process Development, Biologics Drug Product Development, Sanofi-Germany

11:45 Patent protection for improved biopharmaceutical formulations: Significant commercial opportunities and legal challenges
Trevor Crosse – Partner, Marks & Clerk Law LLP, UK

12:15 Lunch Break, Exhibition and Posters

13:30 Introduction to the afternoon session

13:45 Discussion panel

14:45 Exhibitors highlights

15:30 Coffee break, Exhibition and Posters

16:00 Peptide aggregation and physical instability: a challenge in the development of parenteral formulations
Sophie Houvenagel – Scientist I Dosage Form Design and Development, Astra Zeneca, UK

16:30 Understanding formulations: looking beyond preferential exclusion
Paul Dalby – Professor of Biochemical Engineering and Biotechnology, UCL, UK

17:00 Concluding remarks

17:10 Conference ends